Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
about
Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo.Modulation of the p53 family network by RNA-binding proteins.Inhibiting ERK/Mnk/eIF4E broadly sensitizes ovarian cancer response to chemotherapy.MNK1/2 inhibition limits oncogenicity and metastasis of KIT-mutant melanoma.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update
P2860
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@en
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@nl
type
label
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@en
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@nl
prefLabel
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@en
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@nl
P2093
P2860
P1433
P1476
Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia.
@en
P2093
Diana Saleiro
Ewa M Kosciuczuk
Leonidas C Platanias
P2860
P304
P356
10.1016/J.CYTO.2016.01.024
P577
2016-04-16T00:00:00Z